We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Results 1 to 5 of 9
Most popular |Most recent


Court affirms utility of Gleevec patent

Canada - February 20 2013 "Sound prediction's introduction into Canadian law was not, as I understand it, to give a crushing hammer to those who challenge patents." Snider J...

Jennifer L. Wilkie.


Impeachment action permitted to continue for expired patent to nourish subsequent damages proceeding - Apotex Inc. v. Warner-Lambert Co., 2012 FCA 323, December 5, 2012 - quinapril)

Canada - December 14 2012 This was an appeal from an order dismissing part of an impeachment action....


Court of Appeal comment on judicial comity - Apotex Inc. v. Allergan Inc., 2012 FCA 308, November 23, 2012 - brimonidine-timop

Canada - December 14 2012 Justice Noël writing for the Court of Appeal disagreed with Apotex’s appeal of Justice Hughes’ decision to grant an order of prohibition with respect of the NOC for Apo-brimonidine-timop until expiry of the relevant patent....


Important recent trends in pharmaceutical patent litigation

Canada - June 28 2011 From a patentee’s perspective, the patent litigation landscape in 2010 and continuing into 2011 appears to have shifted to a more hospitable environment for innovators....

Jennifer L. Wilkie.


Health Canada releases 2009 statistical report on the administration of the Patented Medicines (Notice of Compliance) Regulations

Canada - November 24 2010 The Therapeutic Products Directorate recently issued its report on the administration of the Patented Medicines (Notice of Compliance) Regulations for 2009....